Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cytotherapy|October 21, 2005
Innovative strategies for PBPC mobilizationS Fruehauf, T Seeger, J Topaly
Leukemia|March 10, 2001
Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cellsJ Topaly, W J Zeller, S Fruehauf
Annals of Hematology|July 12, 2001
Pulmonary artery hypertension during interferon-alpha therapy for chronic myelogenous leukemiaS Fruehauf, S Steiger, J Topaly, et al.
British Journal of Cancer|May 3, 2002
Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioningJ Topaly, S Fruehauf, A D Ho, et al.
Journal of Leukocyte Biology|February 28, 2002
Functional characterization of podia formation in normal and malignant hematopoietic cellsS Fruehauf, K Srbic, R Seggewiss, et al.
Journal of Leukocyte Biology|April 26, 2003
Imatinib restores expression of CD62L in BCR-ABL-positive cellsS Fruehauf, J Topaly, M Schad, et al.
British Journal of Haematology|June 3, 1999
Peripheral blood progenitor cell (PBPC) counts during steady-state haemopoiesis enable the estimation of the yield of mobilized PBPC after granulocyte colony-stimulating factor supported cytotoxic chemotherapy: an update on 100 patientsS Fruehauf, K Schmitt, M R Veldwijk, et al.
Bone Marrow Transplantation|July 15, 2009
Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patientsS Fruehauf, G Ehninger, K Hübel, et al.
Leukemia|May 20, 2005
Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL--Inhibition of P-glycoprotein function by 17-AAGA Radujkovic, M Schad, J Topaly, et al.
Bone Marrow Transplantation|April 24, 2007
Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myelomaS Fruehauf, J Klaus, J Huesing, et al.
Pageof 1